5Tuomi T,Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42:359 -62.
6Groop LC, Bottazzo GF,Doniach D. Islet cell antibodies identify latent type Ⅰ diabetes in patients aged 35- 75 years at diagnosis. Diabetes,1986,35:237- 41.
7Turner R, Stratton I, Horton V, et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet, 1997,350 (9087): 1288- 93.
8Bruno G, De Salvia A, Arcari R, et al. Clinical,immunological,and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30 - 54 years. Diabetes Care, 1999,22 ( 1 ): 50- 55.
9Niskanen LK, Tuomi T, Karjalainen J, et al. GAD antibodies in NIDDM: ten- year follow- up from the diagnosis. Diabetes Care,1995,(12) :1557- 650.
10Groop LC.Bottazzo GF,Doniach D.Islet cell antibodies identify latent type I diabetes in-patients aged 35-75 years at diagnosis[J].Diabetes 1986,35: 237～241.
